Periostat litigation settled
Executive Summary
CollaGenex, West-ward settle litigation over periodontal therapy Periostat. West-ward stipulates CollaGenex' patents are valid and infringed by its ANDA; CollaGenex will pay $700,000 to cover portion of West-ward legal fees. Litigation with Mutual continues. CollaGenex won a preliminary injunction against approval of generics in July (1"The Pink Sheet" July 28, 2003, p. 10)...